2024 - Dosimetry in clinical trials
Date2024-10-24
Deadline2024-10-24
VenueONLINE-VIRTUAL, USA - United States
KeywordsLife Sciences; Clinical Trials; Pharmaceutical
Topics/Call fo Papers
Imaging and therapeutic dosimetry in precision nuclear medicine
Dosimetry is a well-established approach for routine treatment planning in radiation therapy. The dose of radiation energy absorbed by targeted and surrounding tissue is one of the main parameters that determines the biologic effect of radiation. Therefore, the estimation of absorbed radiation serves as an essential tool for making radiation-based treatments less damaging to the heathy tissue.
The physical and pharmacokinetic interactions of radiopharmaceuticals in the body add complexity to the internal dosimetric process required for radionuclide treatments. Lesion- or organ-based dosimetry approaches can yield parameters that have been extensively studied, such as lesion dose-response correlation, dose-volume histogram and dose heterogeneity map findings. These capabilities allow dosimetric data to offer a more suitable correlation between biologic effect and clinical outcomes.
Register for this webinar today to understand the vital role of dosimetry in enhancing radiation-based treatments and minimizing damage to healthy tissue.
Keywords: Drug Development, Precision Medicine, Clinical Research, CRO, Oncology, Radiology, Therapeutic Areas, Radiotherapy, Radiopharmaceuticals, Oncology Drug Development, Dosimetry
Dosimetry is a well-established approach for routine treatment planning in radiation therapy. The dose of radiation energy absorbed by targeted and surrounding tissue is one of the main parameters that determines the biologic effect of radiation. Therefore, the estimation of absorbed radiation serves as an essential tool for making radiation-based treatments less damaging to the heathy tissue.
The physical and pharmacokinetic interactions of radiopharmaceuticals in the body add complexity to the internal dosimetric process required for radionuclide treatments. Lesion- or organ-based dosimetry approaches can yield parameters that have been extensively studied, such as lesion dose-response correlation, dose-volume histogram and dose heterogeneity map findings. These capabilities allow dosimetric data to offer a more suitable correlation between biologic effect and clinical outcomes.
Register for this webinar today to understand the vital role of dosimetry in enhancing radiation-based treatments and minimizing damage to healthy tissue.
Keywords: Drug Development, Precision Medicine, Clinical Research, CRO, Oncology, Radiology, Therapeutic Areas, Radiotherapy, Radiopharmaceuticals, Oncology Drug Development, Dosimetry
Other CFPs
- Medical Device Safety: The Next Frontier
- Operationalizing Innovative Biomarkers to Support Evolving Therapeutic and Diagnostic Landscape for Neurodegenerative Diseases
- Safety-focused from Start to Submission: A Story of Target Safety Assessment and ICH S1B (R1) Guidelines
- Considerations on the Evolving Testing Requirements for Environmental Fate Studies
- Embracing a Culture of Quality: Establishing and Maintaining Effective CRO Oversight
Last modified: 2024-09-17 05:18:12